Our results showed that the combination of the two prognostic factors can divide NPC patients into clear survival groups and that NPC patients with higher CD8 + CD28- T cells and EBV > 1500 have a worse prognosis, which can be a new method for predicting NPC prognosis and stratifying NPC patients. The gene discussed is CD28; the disease is nasopharyngeal carcinoma.